The therapies target diseases and conditions ranging from leukemia to muscular dystrophy to vision loss ... five patient prep and recovery bays, an anesthesia induction room, and space for a ...

Becker muscular dystrophy (BMD), an X-linked muscular dystrophy ... Whole blood was collected from the abdominal aorta under anesthesia with isoflurane in WT, d45–48, d45–47, d45–49 and mdx mice at 1, ...

Calf implants are a relatively straightforward surgery that can be performed under general anesthesia or local anesthesia with ... due to genetics or medical conditions such as polio or muscular ...

Posters presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference highlight the complex care ...

Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy, ...

Cambridge, Mass.-based Sarepta Therapeutics reported the first known death from its Duchenne muscular dystrophy gene therapy ...

Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed down) disorder. The condition is ...

The study uncovers the molecular 'rules' driving the arrangement of emerin into nanoclusters and the mechanisms leading to their defective assembly in people with muscular dystrophy. A new ...

When the Muscular Dystrophy Association (MDA) was founded in 1950, research on this group of disorders was limited—and treatment options even more so. 1 In the years that followed, advocacy ...

Duchenne muscular dystrophy is a genetic disorder characterized by the progressive loss of muscle mass, due to mutations in the dystrophin gene. Without the corresponding functional protein ...

Duchenne muscular dystrophy (DMD) is a genetic condition that primarily affects people assigned male at birth. However, due to the condition’s X-linked inheritance pattern, only people assigned ...